Core Laboratories N.V. (CLB) Financial Statements (2023 and earlier)
Company Profile
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2021
| 12/31/2020
| 12/31/2019
| 12/31/2018
| 12/31/2017
| 12/31/2016
| 12/31/2015
|
|
ASSETS |
|
Current Assets |
|
Cash, cash equivalents, and short-term investments | 17,703 | 13,806 | 11,092 | 13,116 | 14,400 | 14,764 | 22,494 |
|
Cash and cash equivalents | 17,703 | 13,806 | 11,092 | 13,116 | 14,400 | 14,764 | 22,494 |
|
Receivables | 106,741 | 92,867 | 138,106 | 143,150 | 140,605 | 120,755 | 152,898 |
|
Inventory, net of allowances, customer advances and progress billings | 45,443 | 38,151 | 50,163 | 45,664 | 33,317 | 33,720 | 40,906 |
|
Inventory | 45,443 | 38,151 | 50,163 | 45,664 | 33,317 | 33,720 | 40,906 |
|
Prepaid expense | 14,059 | 14,797 | 15,951 | 15,351 | 12,592 | 10,711 | 12,053 |
|
Other current assets | 5,109 | 6,227 | 5,925 | 13,696 | 6,513 | 6,511 | 10,196 |
|
Total current assets: | 189,055 | 165,848 | 221,237 | 230,977 | 207,427 | 186,461 | 238,547 |
|
Noncurrent Assets |
|
Operating lease, right-of-use asset | 61,387 | 66,385 | 75,697 | ✕ | ✕ | ✕ | ✕ |
|
Property, plant and equipment | 110,952 | 115,293 | 123,506 | 122,917 | 123,098 | 129,882 | 143,211 |
|
Long-term investments and receivables | | | | | 3,557 | 3,224 | 2,719 |
|
Long-term investments | | | | | 3,557 | 3,224 | 2,719 |
|
Intangible assets, net (including goodwill), including: | 107,584 | 108,028 | 230,875 | 232,466 | 188,440 | 188,980 | 188,200 |
|
Goodwill | 99,445 | 99,445 | 213,425 | 219,412 | 179,044 | 179,044 | 178,159 |
|
Intangible assets, net (excluding goodwill) | 8,139 | | 17,450 | 13,054 | 9,396 | 9,936 | 10,041 |
|
Other undisclosed intangible assets, net (including goodwill) | | 8,583 | | | | | |
|
Contract with customer, asset, net | | | 244 | | ✕ | ✕ | ✕ |
|
Deferred income tax assets | 70,462 | 72,775 | | ✕ | ✕ | ✕ | ✕ |
|
Other noncurrent assets | 41,413 | 40,250 | 56,046 | 51,215 | 55,128 | 47,124 | 43,607 |
|
Deferred tax assets, net | ✕ | ✕ | ✕ | 11,252 | | | |
|
Other undisclosed noncurrent assets | | | 67,068 | | 7,162 | 17,381 | 8,974 |
|
Total noncurrent assets: | 391,798 | 402,731 | 553,436 | 417,850 | 377,385 | 386,591 | 386,711 |
|
TOTAL ASSETS: | 580,853 | 568,579 | 774,673 | 648,827 | 584,812 | 573,052 | 625,258 |
|
LIABILITIES AND EQUITY |
|
Liabilities |
|
Current Liabilities |
|
Accounts payable and accrued liabilities | 64,744 | 66,300 | 78,006 | 77,734 | 80,636 | 82,517 | 97,162 |
|
Accounts payable | 29,726 | 23,028 | 35,611 | 41,155 | 41,697 | 33,720 | 33,474 |
|
Accrued liabilities | 7,683 | 8,399 | 9,382 | 11,113 | 9,227 | 13,668 | 25,480 |
|
Employee-related liabilities | 20,833 | 26,526 | 26,689 | 22,549 | 28,887 | 19,411 | 36,475 |
|
Taxes payable | 6,502 | 8,347 | 6,324 | 2,917 | 825 | 15,718 | 1,733 |
|
Deferred revenue | 1,300 | 953 | 4,473 | ✕ | ✕ | ✕ | ✕ |
|
Debt | | | 11,841 | | | | |
|
Disposal group, including discontinued operation | | | | 1,633 | | | |
|
Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 17,069 | 15,690 | 14,101 |
|
Deferred tax liabilities | ✕ | ✕ | ✕ | | | | (9,731) |
|
Contract with customer, liability | ✕ | ✕ | ✕ | 5,963 | ✕ | ✕ | ✕ |
|
Other undisclosed current liabilities | 24,738 | 22,497 | 17,274 | 17,217 | 7,313 | 5,816 | 19,226 |
|
Total current liabilities: | 90,782 | 89,750 | 111,594 | 102,547 | 105,018 | 104,023 | 120,758 |
|
Noncurrent Liabilities |
|
Long-term debt and lease obligation, including: | 188,636 | 259,433 | 305,283 | 289,770 | 226,989 | 216,488 | 430,987 |
|
Long-term debt, excluding current maturities | 188,636 | 259,433 | 305,283 | 289,770 | 226,989 | 216,488 | 430,987 |
|
Operating lease, liability | 49,286 | 56,108 | 64,660 | ✕ | ✕ | ✕ | ✕ |
|
Other undisclosed long-term debt and lease obligation | (49,286) | (56,108) | (64,660) | | | | |
|
Liabilities, other than long-term debt | 91,583 | 88,008 | 84,041 | 95,610 | 104,073 | 97,244 | 97,212 |
|
Deferred revenue | 435 | 293 | 383 | ✕ | ✕ | ✕ | ✕ |
|
Contract with customer, liability | ✕ | ✕ | ✕ | 1,401 | ✕ | ✕ | ✕ |
|
Deferred compensation liability, classified | 39,101 | 39,145 | 50,485 | 49,359 | 52,786 | 46,251 | 43,478 |
|
Deferred tax liabilities, net | ✕ | ✕ | ✕ | 7,634 | 5,323 | 6,277 | 4,881 |
|
Deferred income tax liabilities | 24,336 | 20,585 | | ✕ | ✕ | ✕ | ✕ |
|
Other liabilities | 27,711 | 27,985 | 33,173 | 37,216 | 45,964 | 44,716 | 48,853 |
|
Other undisclosed noncurrent liabilities | 48,851 | 55,815 | 91,615 | | | | |
|
Total noncurrent liabilities: | 329,070 | 403,256 | 480,939 | 385,380 | 331,062 | 313,732 | 528,199 |
|
Total liabilities: | 419,852 | 493,006 | 592,533 | 487,927 | 436,080 | 417,755 | 648,957 |
|
Stockholders' equity |
|
Stockholders' equity attributable to parent | 156,449 | 71,513 | 177,865 | 156,759 | 144,844 | 151,354 | (29,064) |
|
Common stock | 1,188 | 1,148 | 1,148 | 1,148 | 1,148 | 1,148 | 1,142 |
|
Treasury stock, value | (4,075) | (14,075) | (29,364) | (52,501) | (76,269) | (80,773) | (238,875) |
|
Additional paid in capital | 101,120 | 41,184 | 51,872 | 57,438 | 54,463 | 52,850 | |
|
Accumulated other comprehensive loss | (10,133) | (7,200) | (6,330) | (5,456) | (8,353) | (9,828) | (10,538) |
|
Retained earnings | 68,349 | 50,456 | 160,539 | 156,130 | 173,855 | 187,957 | 219,207 |
|
Stockholders' equity attributable to noncontrolling interest | 4,552 | 4,060 | 4,275 | 4,141 | 3,888 | 3,943 | 5,365 |
|
Total stockholders' equity: | 161,001 | 75,573 | 182,140 | 160,900 | 148,732 | 155,297 | (23,699) |
|
TOTAL LIABILITIES AND EQUITY: | 580,853 | 568,579 | 774,673 | 648,827 | 584,812 | 573,052 | 625,258 |
Income Statement (P&L) ($ in thousands)
Comprehensive Income ($ in thousands)
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission
(SEC)
through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from
the 10-K and 10-Q reports submitted
to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP
Taxonomy.
Please review the original filings
for a more detailed information.